Actively Recruiting

Age: 18Years +
All Genders
NCT06518278

Assessing Central Aspects of Pain

Led by University of Nottingham · Updated on 2026-04-08

250

Participants Needed

1

Research Sites

101 weeks

Total Duration

On this page

Sponsors

U

University of Nottingham

Lead Sponsor

K

King's College London

Collaborating Sponsor

AI-Summary

What this Trial Is About

BACKGROUND: Chronic pain continues for more than 12 weeks despite medication or treatment. Chronic pain is the main symptom of muscle and joint problems, rarely explained by damage to the muscle and joints alone. Activity in the central nervous system (CNS; nerves, spinal cord, and brain) pathways governs our ability to describe pain intensity and our emotional response to pain. Musculoskeletal conditions (e.g., inflammatory arthritis, osteoarthritis, low back pain, fibromyalgia) share altered CNS pathways, acknowledged by recent classifications of 'primary' and 'nociplastic' pain. Clinically useful tools to diagnose and measure activity and reveal abnormalities in these CNS pathways are needed to improve clinical decisions and accelerate new treatment development. Laboratory pain sensitivity testing and brain imaging confirm the CNS as a primary contributor to pain. These assessments are less acceptable or unfeasible for clinical practice. Simpler clinical pain sensitivity assessments are being developed. The investigators simple Central Aspects of Pain (CAP) questionnaire detects some people with pain sensitivity and knee, rheumatoid arthritis or low back pain. Combining the CAP questionnaire reflecting emotional processing and simpler pain sensitivity assessment, combining two different dimensions should be better than either approach alone. PURPOSE: To optimise diagnosis and measurement of CNS as the primary contribution to chronic musculoskeletal pain by using the CAP questionnaire and simpler pain sensitivity assessments to ensure timely, effective diagnosis and treatment. OBJECTIVES: 1. Assess the ease, ability and performance of the combined CAP questionnaire and simpler pain sensitivity assessments to identify CNS as the primary contributor to chronic pain across musculoskeletal conditions. 2\. Use the CAP questionnaire alone or with substitute measures of activity in CNS pathways, demographic, and clinical variables to indicate pain levels at six and twelve weeks. 3\. Understand the relationship between CAP and simpler pain sensitivity assessment with laboratory pain sensitivity assessments as a tool to inform the current CNS activity contributing to pain. 4\. Evaluate associations between the CAP questionnaire and simpler pain sensitivity assessments with patient outcomes.

CONDITIONS

Official Title

Assessing Central Aspects of Pain

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or over.
  • Self-reported diagnosis of fibromyalgia, inflammatory musculoskeletal condition (e.g., rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis), low back pain, or osteoarthritis.
  • Musculoskeletal diagnosis and pain onset more than 3 months before baseline.
  • Self-reported pain level of 3 or higher on a 0 to 10 scale on most days in the 3 months before baseline.
  • Ability to give informed consent.
Not Eligible

You will not qualify if you...

  • Terminal or uncontrolled medical or mental health condition preventing completion of assessments or posing significant risk.
  • Insufficient understanding of spoken or written English to follow the study protocol.
  • Inability to adhere to the study protocol.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Nottingham, Academic Rheumatology, IRIS, School of Medicine

Nottingham, Nottingham, United Kingdom, NG5 1PB

Actively Recruiting

Loading map...

Research Team

S

Stephanie L Smith, PhD

CONTACT

D

David A Walsh, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here